BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Down 79.3% in June

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 3,500 shares, a decrease of 79.3% from the May 31st total of 16,900 shares. Based on an average daily volume of 56,600 shares, the days-to-cover ratio is currently 0.1 days.

BriaCell Therapeutics Stock Up 1.9 %

NASDAQ BCTXW traded up $0.00 on Friday, reaching $0.27. 74,052 shares of the company’s stock traded hands, compared to its average volume of 37,475. BriaCell Therapeutics has a 12 month low of $0.17 and a 12 month high of $3.30. The stock has a 50-day simple moving average of $0.60 and a 200 day simple moving average of $1.26.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.